Biologic treatments in Behçet’s disease

QR Code

Biologic treatments in Behçet’s disease

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fatma Alibaz-Öner, Haner Direskeneli
Format:	article
Langue:	EN
Publié:	AVES Yayincilik 2021
Sujets:	Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/49bb77033fad4823911fc509aef22d4e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
par: Yusuf Karabulut
Publié: (2021)

Clinical manifestations of Behçet’s syndrome: A single-center cohort of 777 patients
par: Cemal Gürbüz, et autres
Publié: (2021)

Acute necrotizing pancreatitis as a manifestation of Behcet’s Disease: A case report and review of the literature
par: Geilan A. Mahmoud, et autres
Publié: (2022)

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
par: Cosimo Bruni, et autres
Publié: (2021)

Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions
par: E. S. Sorozhkina, et autres
Publié: (2021)

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
par: Helene Broch Tenstad, et autres
Publié: (2021)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
par: Zhou DT, et autres
Publié: (2015)

EFFECT OF HUMAN HERPES VIRUS REACTIVATION ON SYSTEMIC CYTOKINE PRODUCTION IN PATIENTS WITH BEHCET’S DISEASE AND UVEITIS
par: G. I. Krichevskaya, et autres
Publié: (2021)

Ginger extract suppresses the activations of NF-κB and Wnt pathways and protects inflammatory arthritis
par: Burak Öz, et autres
Publié: (2021)

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc
par: Eva Poveda, et autres
Publié: (2010)

IMMUNOLOGY OF EYE DISEASES
par: Article Editorial
Publié: (2015)

The use of preexposure treatments for HIV prophylaxis
par: Majid A, et autres
Publié: (2012)

IMMUNOLOGY OF URINARY SYSTEM DISEASES
par: Article ed
Publié: (2015)

IMMUNOLOGY OF CARDIOVASCULAR SYSTEM DISEASES
par: Article Editorial
Publié: (2015)

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
par: Alana MacDonald, et autres
Publié: (2021)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
par: Pandey KK
Publié: (2014)

Profile of darunavir in the management of treatment-experienced HIV patients
par: Cameron Wolfe, et autres
Publié: (2009)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
par: Sicong Li, et autres
Publié: (2021)

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
par: Patel TS, et autres
Publié: (2013)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
par: Osterholzer D
Publié: (2013)

Long-term treatment of patients with HIV-1: the role of atazanavir
par: Miguel &Aacute;ngel Artacho, et autres
Publié: (2010)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
par: Beatriz Larru Martinez, et autres
Publié: (2010)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
par: Michael A Horberg, et autres
Publié: (2010)

Effect of once-daily FDC treatment era on initiation of cART
par: David M Mosen, et autres
Publié: (2010)

Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
par: Pullen SD, et autres
Publié: (2014)

Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia
par: Demissie K, et autres
Publié: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Article Editorial
Publié: (2015)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. ALLERGIC DISEASES
par: Editorial article
Publié: (2014)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY OF IMMUNOPATHOLOGICAL STATES. AUTOIMMUNE DISEASES
par: Editorial article
Publié: (2014)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
par: Luiz Felipe Domingues Passero, et autres
Publié: (2021)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
par: Seddon J, et autres
Publié: (2011)

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
par: Thore Lorenzen
Publié: (2010)